Format

Send to

Choose Destination
Ann Neurol. 2016 Dec;80(6):946-951. doi: 10.1002/ana.24807. Epub 2016 Nov 14.

Prothrombin and factor X are elevated in multiple sclerosis patients.

Author information

1
Department of Neurology, University of Münster, Münster.
2
Department of Neurology, University Hospital Würzburg, Würzburg.
3
Institute of Biostatistics and Clinical Research, University of Münster, Münster.
4
Department of Medicine A, University Hospital Münster, Münster.
5
Department of Anesthesiology, Intensive Care, and Pain Medicine, Experimental and Clinical Hemostasis, University of Münster, Münster.
6
Department of Neurology, University Hospital Essen, Essen, Germany.

Abstract

Animal models have implicated an integral role for coagulation factors in neuroinflammatory diseases such as multiple sclerosis (MS) beyond their role in hemostasis. However, their relevance in humans requires further elucidation. This study aimed to determine whether levels of coagulation factors differ between patients with neuroimmunological disorders and respective controls. Individuals suffering from relapsing-remitting and secondary progressive MS had significantly higher prothrombin and factor X levels than healthy donors, whereas levels were unchanged in primary progressive MS and neuromyelitis optica patients. Our study demonstrates that coagulation factors may be key mediators in neuroinflammation and may therefore provide future targets for therapeutic strategies. Ann Neurol 2016;80:946-951.

PMID:
27774643
DOI:
10.1002/ana.24807
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center